Total words: 906 | 2-word phrases: 235 | 3-word phrases: 258 | 4-word phrases: 264
Title | Try to keep the title under 60 characters (67 characters) HCM Clinical Trial Addressing the MYBPC3 Gene - Tenaya Therapeutics |
Description | Try to keep the meta description between 50 - 160 characters (126 characters) Tenaya is enrolling participants in clinical trials to address mutations of the MYBPC3 gene, the leading genetic cause of HCM. |
Keywords | Meta keywords are not recommended anymore (0 characters) |
H1 | H1 tag on the page (61 characters) Participate in Research for Hypertrophic Cardiomyopathy (HCM) |
# | Keyword | H1 | Title | Des | Volume | Position | Suggest | Frequency | Density |
---|---|---|---|---|---|---|---|---|---|
1 | hcm | 13 | 8.72% | ||||||
2 | the | 12 | 8.05% | ||||||
3 | to | 10 | 6.71% | ||||||
4 | gene | 9 | 6.04% | ||||||
5 | of | 8 | 5.37% | ||||||
6 | a | 8 | 5.37% | ||||||
7 | for | 7 | 4.70% | ||||||
8 | more | 6 | 4.03% | ||||||
9 | learn | 6 | 4.03% | ||||||
10 | therapy | 6 | 4.03% |
# | URL | Whois | Check |
---|---|---|---|
1 | https://twitter.com/TenayaThera | Whois | twitter.com |
2 | https://www.linkedin.com/company/tenaya-therapeutics/ | Whois | linkedin.com |
3 | https://www.tenayatherapeutics.com/expanded-access-policy/ | Whois | tenayatherapeutics.com |
4 | https://www.tenayatherapeutics.com/privacy-policy/ | Whois | tenayatherapeutics.com |
5 | https://www.tenayatherapeutics.com/terms-of-use/ | Whois | tenayatherapeutics.com |